High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$2.4M
$2,358,060
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RLMD |
RELMADA THERAPEUTICS, INC.
|
CFO
Discretionary Buy
|
2025-12-15 | $48,060 | P | Form 4 |
| RLMD |
RELMADA THERAPEUTICS, INC.
|
CEO
Discretionary Buy
|
2025-12-15 | $113,300 | P | Form 4 |
|
RLMD
P
RELMADA THERAPEUTICS, INC.
Kelly Paul Edward
• COO
Discretionary BuyΔOwn +21.8%
2025-11-05
$198,000
|
||||||
| RLMD |
RELMADA THERAPEUTICS, INC.
|
COO
Discretionary BuyΔOwn +21.8%
|
2025-11-05 | $198,000 | P | Form 4 |
|
RLMD
P
RELMADA THERAPEUTICS, INC.
Shenouda Maged
• CFO
Discretionary BuyΔOwn +173.4%
2025-11-05
$1,100,000Large
|
||||||
| RLMD |
RELMADA THERAPEUTICS, INC.
|
CFO
Discretionary BuyΔOwn +173.4%
|
2025-11-05 | $1,100,000Large | P | Form 4 |
|
RLMD
P
RELMADA THERAPEUTICS, INC.
TRAVERSA SERGIO
• CEO
Discretionary BuyΔOwn +27.2%
2025-11-05
$599,500
|
||||||
| RLMD |
RELMADA THERAPEUTICS, INC.
|
CEO
Discretionary BuyΔOwn +27.2%
|
2025-11-05 | $599,500 | P | Form 4 |
| RLMD |
RELMADA THERAPEUTICS, INC.
|
COO
Discretionary BuyΔOwn +50.8%
|
2025-11-05 | $299,200 | P | Form 4 |